Carmentix, U of Melbourne Launch Prenatal Biomarkers Initiative

Dec 12, 2016

|

NEW YORK (GenomeWeb) – Singapore-based company Carmentix Private Limited and Australia's University of Melbourne announced a new initiative last week to discover biomarkers related to preterm birth.

"Carmentix is excited to begin this collaboration, as we are keen to further develop the biomarkers discovered on our unique data mining platform," CEO Nir Arbel said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Carmentix, U of Melbourne Launch Prenatal Biomarkers Initiative

To read the full story....

Breaking News

AACC Issues Revised Guidance on Management of Point-of-Care Testing

In Brief This Week: Quest Diagnostics, Novacyt, Natera, and More

CDC Develops Test for Simultaneous Detection of COVID-19, Flu

Randox Laboratories Invests $33.7M to Increase Coronavirus Testing Capacity

Roche Garners FDA Emergency Use Authorization for Elecsys IL-6 Test in COVID-19 Patients

Immunovia Raises $43.0M Through Stock Issuance

Featured White Papers

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

What's Popular?

Roche Garners FDA Emergency Use Authorization for Elecsys IL-6 Test in COVID-19 Patients

Beset by COVID-19 Pandemic, Europe Searches for Right Test Mix for Diagnosis, Surveillance

FDA Issues Emergency Use Authorizations for Gravity Diagnostics, Aspirus, CSI Coronavirus Tests

Randox Laboratories Invests $33.7M to Increase Coronavirus Testing Capacity

At-Home Coronavirus Tests Get Nod From FDA But Agency Proceeding With Caution

Sponsorships